Louisiana is one of 30 states with criminal penalties related to HIV exposure. Most were created in the 1980s during the AIDS ...

ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...

Participants who initiated long-acting cabotegravir-rilpivirine had a high rate of adherence and virologic suppression, with ...

Pepfar, a global programme to fight HIV/Aids, has been exempted from US President Donald Trump’s plan to slash billions in ...

The loss of federal funding from the Centers for Disease Control comes as Memphis health officials face rising rates of new ...

TB can be cured, but ridding the body of the bug often takes many months and usually requires taking four or more different medicines. In this Spotlight special briefing, we zoom in on what makes the ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

How will the Trump administration's cuts to HIV research impact the progress that's been made towards ending the epidemic in the U.S.?

The Food and Drug Administration (FDA) recently approved lenacapavir for HIV prevention in both men and women. Many experts believe this twice a year treatment could be a game changer in the fight … ...

Discover how understanding your viral load and CD4 count puts you in control of HIV treatment and transforms confusing numbers into power.

More than half a million people previously diagnosed with HIV have been started on HIV treatment since the end of February, the health minister says. But can a big jump in 10 weeks really be? We look ...

The mid-to-late stage trials were testing the oral combination treatment against Biktarvy, Gilead's once-a-day pill to treat HIV.